Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

By adding a microRNA molecule to ALS models, Tel Aviv University, Ben-Gurion University and Weizmann Institute researchers ...

Presidents have few tools to fight inflation. Trump himself seems reluctant to acknowledge that a problem even exists.

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a full-service cell and gene ...

Pluristyx’s platform technology was developed specifically to overcome this challenge. This Breakthrough T1D collaboration will fund the use of precise gene editing to engineer Pluristyx’s exclusively ...

Cincinnati Children's said up to 100 employees will eventually work at the site, a count that includes 24 new roles.

Uricase helps break down uric acid, a waste product in the blood. Without enough uricase, uric acid builds up, forming ...